In an early stage clinical trial, Moderna’s COVID-19 vaccine produced antibodies that will help ‘neutralize’ coronavirus in patients. Moderna CEO Stéphane Bances joins Yahoo Finance’s On the Move to discuss.
from Yahoo Finance https://ift.tt/2ygEToo
Sorry, but nothing was found. Please try a search with different keywords.